Xilin Zhou
-
- Diabetes Management and Education 4
- Diabetes Management and Research 4
-
- Chronic Disease Management Strategies 2
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Healthcare Policy and Management 3
-
- Synthesis and Characterization of Heterocyclic Compounds 3
-
- Health disparities and outcomes 3
-
- Biochemical and Molecular Research 2
- Co-authors
- Ping ZhangBoon Peng NgKrista K. ProiaAnn AlbrightXuanping ZhangKaren R. SiegelMohammed K. AliEdward W. Gregg
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Diabetes Care (5 papers)
- Partner nations
- United StatesChina
In The Last Decade
Xilin Zhou
16 papers receiving 378 citations
Peers
Comparison fields: 5 of 79
- Endocrinology, Diabetes and Metabolism 147
- Family Practice 15
- General Health Professions 77
- Pharmacy 14
- Epidemiology 91
Countries citing papers authored by Xilin Zhou
This map shows the geographic impact of Xilin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilin Zhou more than expected).
Fields of papers citing papers by Xilin Zhou
This network shows the impact of papers produced by Xilin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilin Zhou. The network helps show where Xilin Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xilin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 19 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 35 | |
| 12 | 2020 | 85 | |
| 13 | 2020 | 95 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 8 | |
| 16 | 2017 | 32 | |
| 17 | Synthesis of bicyclic thieno[2,3-d]pyrimidines, tricyclic thieno[2,3-d]pyrimidines and thieno[3,2-d]pyrimidines as classical and nonclassical antifolates | 2012 | 0 |
| 18 | 2009 | 68 |
About Xilin Zhou
Xilin Zhou is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism and Health, having authored 18 papers that have together received 382 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Diabetes Management and Education (4 papers), Diabetes Management and Research (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Health disparities and outcomes (3 papers), Healthcare Policy and Management (3 papers), Chronic Disease Management Strategies (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (147 citations), Family Practice (15 citations) and General Health Professions (77 citations). Xilin Zhou has collaborated with scholars based in United States and China. Frequent co-authors include Ping Zhang, Boon Peng Ng, Krista K. Proia, Ann Albright, Xuanping Zhang, Karen R. Siegel, Mohammed K. Ali, Edward W. Gregg, Guijing Wang and Aleem Gangjee. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.